| Sunday
1:00 PM | SU-E-202-1 : Uncertainty Analysis of Absorbed Dose Calculation in Targeted Radiotherapy Using a Bayesian Approach
M. BENSIALI*, E. Davesne, E. Chojnacki, D. Broggio, S. Lamart, N. Anizan, S. Leboulleux, D. Franck |
| Sunday
1:07 PM | SU-E-202-2 : Commissioning of a Commercial Whole-Body Gamma Camera Image-Based Radiopharmaceutical Therapy Treatment Planning System
W. Erwin* |
| Sunday
1:14 PM | SU-E-202-3 : CT Metallic Artifacts Affect Clinical, SPECT Image-Based, Iodine-131 Radiopharmaceutical Therapy Dosimetry
D. Adam*, T. Bradshaw, P. Hill, J. Grudzinski, S. Cho, A. Burr, P. Harari, B. Bednarz |
| Sunday
1:21 PM | SU-E-202-4 : Comparing Methods for Fitting and Integrating the Time-Activity Curve (TAC): Impact On Clinical Dosimetry After 177Lu-PRRT
R. Danieli*, Y. Dewaraja, D. Raspanti, M. Ferrari, F. Botta, G. Glatting, M. Cremonesi |
| Sunday
1:28 PM | SU-E-202-5 : Impact of Dosimetry Method On Organ and Tumor Absorbed Dose Estimates in Lutetium-177-DOTATATE Therapy of Neuroendocrine Tumors
J. Brosch-Lenz*, A. Rahmim, C. Uribe |
| Sunday
1:35 PM | SU-E-202-6 : Voxel-Wise Preclinical Dosimetry of 177Lu-NM600 Using the Monte Carlo-Based Platform RAPID
O. Kwon*, J. Grudzinski, D. Adam, P. Clark, R. Sriramaneni, C. Ferreira, J. Jeffery, C. Massey, C. Kerr, Z. Morris, R. Hernandez, J. Weichert, B. Bednarz |
| Sunday
1:42 PM | SU-E-202-7 : A Macroscale Model of the Adult Human Kidney with Arterial and Venous Cortical Vasculature for Applications in Radiopharmaceutical Dosimetry
A. Dozic*, J. Aris, C. Correa Alfonso, S. Domal, J. Withrow, S. Xing, L. McCullum, C. Grassberger, H. Paganetti, W. Bolch |
| Sunday
1:49 PM | SU-E-202-8 : Computational Benchmarking of Nanoscale Dosimetry in DNA Damaged by 125I Decay
O. Kwon*, B. Bednarz |
